152 related articles for article (PubMed ID: 16326028)
21. [Gene atm and chronic lymphocytic leukemia - review].
Zhu DX; Xu W; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1242-6. PubMed ID: 18928637
[TBL] [Abstract][Full Text] [Related]
22. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
Mittal AK; Hegde GV; Aoun P; Bociek RG; Dave BJ; Joshi AD; Sanger WG; Weisenburger DD; Joshi SS
Int J Mol Med; 2007 Oct; 20(4):461-9. PubMed ID: 17786276
[TBL] [Abstract][Full Text] [Related]
23. Peripheral blood complete remission after splenic irradiation in mantle-cell lymphoma with 11q22-23 deletion and ATM inactivation.
Filippi AR; Franco P; Galliano M; Ricardi U
Radiat Oncol; 2006 Sep; 1():35. PubMed ID: 16956411
[TBL] [Abstract][Full Text] [Related]
24. A unique lethal blastoid transformation of B-cell chronic lymphocytic leukemia carrying ATM/11q deletion and trisomy 12.
Lu Y; Huang Q
Leuk Res; 2009 Aug; 33(8):e124-6. PubMed ID: 19269030
[No Abstract] [Full Text] [Related]
25. Toward a comprehensive prognostic scoring system in chronic lymphocytic leukemia based on a combination of genetic parameters.
Haferlach C; Dicker F; Weiss T; Schnittger S; Beck C; Grote-Metke A; Oruzio D; Kern W; Haferlach T
Genes Chromosomes Cancer; 2010 Sep; 49(9):851-9. PubMed ID: 20552631
[TBL] [Abstract][Full Text] [Related]
26. New insights into the pathogenesis of chronic lymphocytic leukemia.
Klein U; Dalla-Favera R
Semin Cancer Biol; 2010 Dec; 20(6):377-83. PubMed ID: 21029776
[TBL] [Abstract][Full Text] [Related]
27. Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14.
Ouillette P; Erba H; Kujawski L; Kaminski M; Shedden K; Malek SN
Cancer Res; 2008 Feb; 68(4):1012-21. PubMed ID: 18281475
[TBL] [Abstract][Full Text] [Related]
28. Predominantly post-transcriptional regulation of activation molecules in chronic lymphocytic leukemia: the case of transferrin receptors.
Chiotoglou I; Smilevska T; Samara M; Likousi S; Belessi C; Athanasiadou I; Stavroyianni N; Samara S; Laoutaris N; Vamvakopoulos N; Anagnostopoulos A; Fassas A; Stamatopoulos K; Kollia P
Blood Cells Mol Dis; 2008; 41(2):203-9. PubMed ID: 18621559
[TBL] [Abstract][Full Text] [Related]
29. Gene dosage effects in chronic lymphocytic leukemia.
Sellmann L; Scholtysik R; Kreuz M; Cyrull S; Tiacci E; Stanelle J; Carpinteiro A; Nückel H; Boes T; Gesk S; Siebert R; Klein-Hitpass L; Dührsen U; Dürig J; Küppers R
Cancer Genet Cytogenet; 2010 Dec; 203(2):149-60. PubMed ID: 21156227
[TBL] [Abstract][Full Text] [Related]
30. Deletions at 11q23 in different lymphoma subtypes.
Zhu Y; Monni O; Franssila K; Elonen E; Vilpo J; Joensuu H; Knuutila S
Haematologica; 2000 Sep; 85(9):908-12. PubMed ID: 10980627
[TBL] [Abstract][Full Text] [Related]
31. Mantle cell lymphoma is characterized by inactivation of the ATM gene.
Schaffner C; Idler I; Stilgenbauer S; Döhner H; Lichter P
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2773-8. PubMed ID: 10706620
[TBL] [Abstract][Full Text] [Related]
32. Overlapping deletion regions at 11q23 in myelodysplastic syndrome and chronic lymphocytic leukemia, characterized by a novel BAC probe set.
Siew-Gek Lee A; Rudduck-Sivaswaren C; Khun-Hong Lie D; Li-Ming Chua C; Tien SL; Morsberger L; Griffin CA
Cancer Genet Cytogenet; 2004 Sep; 153(2):151-7. PubMed ID: 15350305
[TBL] [Abstract][Full Text] [Related]
33. Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion.
Austen B; Skowronska A; Baker C; Powell JE; Gardiner A; Oscier D; Majid A; Dyer M; Siebert R; Taylor AM; Moss PA; Stankovic T
J Clin Oncol; 2007 Dec; 25(34):5448-57. PubMed ID: 17968022
[TBL] [Abstract][Full Text] [Related]
34. Identification of a potential role for POU2AF1 and BTG4 in the deletion of 11q23 in chronic lymphocytic leukemia.
Auer RL; Starczynski J; McElwaine S; Bertoni F; Newland AC; Fegan CD; Cotter FE
Genes Chromosomes Cancer; 2005 May; 43(1):1-10. PubMed ID: 15672409
[TBL] [Abstract][Full Text] [Related]
35. Inactivation of p53 and deletion of ATM in B-CLL patients in relation to IgVH mutation status and previous treatment.
Trbusek M; Malcikova J; Smardova J; Kuhrova V; Mentzlova D; Francova H; Bukovska S; Svitakova M; Kuglik P; Linkova V; Doubek M; Brychtova Y; Zacal J; Kujickova J; Pospisilova S; Dvorakova D; Vorlicek J; Mayer J
Leukemia; 2006 Jun; 20(6):1159-61. PubMed ID: 16572201
[No Abstract] [Full Text] [Related]
36. Analysis of 11q22-q23 deletion target genes in B-cell chronic lymphocytic leukaemia: evidence for a pathogenic role of NPAT, CUL5, and PPP2R1B.
Kalla C; Scheuermann MO; Kube I; Schlotter M; Mertens D; Döhner H; Stilgenbauer S; Lichter P
Eur J Cancer; 2007 May; 43(8):1328-35. PubMed ID: 17449237
[TBL] [Abstract][Full Text] [Related]
37. DNA-PK, ATM and MDR proteins inhibitors in overcoming fludarabine resistance in CLL cells.
Svirnovski AI; Serhiyenka TF; Kustanovich AM; Khlebko PV; Fedosenko VV; Taras IB; Bakun AV
Exp Oncol; 2010 Dec; 32(4):258-62. PubMed ID: 21270755
[TBL] [Abstract][Full Text] [Related]
38. Incidence and clinical implications of ATM aberrations in chronic lymphocytic leukemia.
Ouillette P; Li J; Shaknovich R; Li Y; Melnick A; Shedden K; Malek SN
Genes Chromosomes Cancer; 2012 Dec; 51(12):1125-32. PubMed ID: 22952040
[TBL] [Abstract][Full Text] [Related]
39. Expression analysis of genes located in the minimally deleted regions of 13q14 and 11q22-23 in chronic lymphocytic leukemia-unexpected expression pattern of the RHO GTPase activator ARHGAP20.
Herold T; Jurinovic V; Mulaw M; Seiler T; Dufour A; Schneider S; Kakadia PM; Feuring-Buske M; Braess J; Spiekermann K; Mansmann U; Hiddemann W; Buske C; Bohlander SK
Genes Chromosomes Cancer; 2011 Jul; 50(7):546-58. PubMed ID: 21500311
[TBL] [Abstract][Full Text] [Related]
40. Imperfect correlation between p53 dysfunction and deletion of TP53 and ATM in chronic lymphocytic leukaemia.
Carter A; Lin K; Sherrington PD; Atherton M; Pearson K; Douglas A; Burford A; Brito-Babapulle V; Matutes E; Catovsky D; Pettitt AR
Leukemia; 2006 Apr; 20(4):737-40. PubMed ID: 16437137
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
